what is compounded tirzepatide GLP-1/GIP Program Compounded Tirzepatide+B12 - Team Wellcore
Description
This study population was divided into two cohorts: (1) semaglutide cohort 25,686 patients prescribed semaglutide, and (2) Non-GLP-1RA anti-diabetes medication cohort 573,117 patients prescribed non-GLP-1RA anti-diabetes medications

Achieving success with Semaglutide involves more than just taking the medication

Seek support from communities of people who have experienced the same thing

Of note, the mixed venous O2 cannot be used to estimate cardiac output when a patient is on VA-ECMO, but low levels still do correlate with poor tissue perfusion and worse outcomes

55% of patients on combination therapy with 37to 44% of patients reaching risk based goals To view or add a comment, sign in Combination Lipid Lowering therapy should be standard of care in high and very high risk pts with FDC single pills to reduce medication burden
